Company intelligence / Profile preview

Akoya Biosciences

Marlborough, Massachusetts, United Statesakoyabio.com ↗

Ownership: Public · QTRX
Employees: ~350
Development stage: Commercial

Overview

Akoya Biosciences offers commercialized spatial phenotyping solutions that enable high-throughput single-cell imaging and multiplexed biomarker discovery. Their platforms are widely adopted by academic centers and biopharma companies for translational research but do not themselves generate clinical trial results as they do not develop therapeutics.

Therapeutic areas: OncologyImmunology
Modalities: DeviceSoftware
Industry: Pathology

Partnerships

Thermo Fisher Scientific (license/distribution agreement)Agilent Technologies (partnership to drive multiplex tissue assay development)

Beyond the preview

Go deeper on Akoya Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Akoya Biosciences.

Explore the full profile